Global X S&P Biotech ETF (ASX:CURE)
Australia · Delayed Price · Currency is AUD 64.58
+0.39 (0.61%)
Jun 1, 2026, 3:06 PM AEST
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Travere Therapeutics stock at 1.79%, Revolution Medicines at 1.78%, Alkermes at 1.71%, Twist Bioscience at 1.61%, and TG Therapeutics at 1.52%.
Total Holdings
10
Top 10 Percentage
15.44%
Asset Class
Equity
ETF Category
Health Care
Assets
41.20M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TVTX | Travere Therapeutics, Inc. | 1.79% |
| 2 | RVMD | Revolution Medicines, Inc. | 1.78% |
| 3 | ALKS | Alkermes plc | 1.71% |
| 4 | TWST | Twist Bioscience Corporation | 1.61% |
| 5 | TGTX | TG Therapeutics, Inc. | 1.52% |
| 6 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.51% |
| 7 | BEAM | Beam Therapeutics Inc. | 1.42% |
| 8 | NBIX | Neurocrine Biosciences, Inc. | 1.37% |
| 9 | KRYS | Krystal Biotech, Inc. | 1.36% |
| 10 | EXEL | Exelixis, Inc. | 1.36% |
As of May 29, 2026